- Home
- / Cambridge Cognition Holdings
Cambridge Cognition Holdings
Stock Price
£0.3
2024-10-29
Market Capitalization
£11.7 M
2024-10-29
Revenue
£13.5 M
FY, 2023
Cambridge Cognition Holdings Summary
Company Summary
- Overview
- Cambridge Cognition Holdings develops and commercializes computerized neuropsychological tests. Company delivers near-patient assessment solutions to improve the understanding, diagnosis, and treatment of neurological and psychiatric disorders.
- Type
- Public
- Status
- Active
- Founded
- 2002
- HQ
- Cambridge, GB | view all locations
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Steven Powell, Chairman
Debra Leeves, Non-Executive Director
Stephen Symonds, Chief Financial Officer
LocationsView all
4 locations detected
Cambridge, England HQ
United Kingdom
Tunbridge Court
Cambridge, MA
United States
One Broadway
Toronto, ON
Canada
100 King Street West, Suite 6200, 1 First Canadian Place
Sandton, GP
South Africa
Lower Ground Suite, Building 9, Somerset Office Park 5, Libertas Road
Cambridge Cognition Holdings Financials
Summary Financials
- Revenue (H1, 2024)
- £5.6M
- Gross profit (H1, 2024)
- £4.9M
- Net income (H1, 2024)
- (£1.1M)
- Cash (H1, 2024)
- £3.4M
- EBIT (H1, 2024)
- (£839.0K)
- Enterprise value
- $10.7M